Management of Extremity Recurrences After Complete Responses to Isolated Limb Perfusion in Patients With Melanoma

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Annals of Surgical Oncology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10434-999-0562-xPMID 10493624
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

  1998cited by this paper
• Isolated limb perfusion in primary and recurrent melanoma: indications and results.

  1998cited by this paper
• Isolated limb reperfusion with tumor necrosis factor and melphalan in patients with extremity melanoma after failure of isolated limb perfusion with chemotherapeutics

  1997cited by this paper
• Frequency and duration of remission after isolated limb perfusion for melanoma.

  1997cited by this paper
• Randomized, double-blind, placebo-controlled trial comparing the response rates of carmustine, dacarbazine, and cisplatin with and without tamoxifen in patients with metastatic melanoma. National Cancer Institute of Canada Clinical Trials Group.

  1996cited by this paper
• A single centre's 10 year experience with isolated limb perfusion in the treatment of recurrent malignant melanoma of the limb.

  1996cited by this paper
• Isolated limb perfusion for malignant melanoma.

  1996cited by this paper
• Continuous intraoperative external monitoring of perfusate leak using iodine-131 human serum albumin during isolated perfusion of the liver and limbs

  1995cited by this paper
• Prognostic factors for tumor response and limb recurrence-free interval in patients with advanced melanoma of the limbs treated with regional isolated perfusion with melphalan.

  1994cited by this paper
• Regional therapy of melanoma.

  1993cited by this paper
• Results of a double perfusion schedule using high-dose hyperthermia and melphalan sequentially for recurrent melanoma of the limbs: a pilot study

  1992cited by this paper
• Effective combination chemo/hormonal therapy for malignant melanoma: Experience with three consecutive trials

  1992cited by this paper
• Prognostic variables in recurrent limb melanoma treated with hyperthermic antiblastic perfusion

  1989cited by this paper
• Value of therapeutic hyperthermic limb perfusion in advanced recurrent melanoma of the lower extremity.

  1985cited by this paper
• The effect of regional perfusion treatment on recurrent melanoma of the extremities.

  1977cited by this paper
• Hyperthermic perfusion with chemotherapy for cancers of the extremities.

  1969cited by this paper
• Hyperthermic perfusion with chemotherapy for cancers of the extremities.

  1969cited by this paper
• Chemotherapy of Cancer: Regional Perfusion Utilizing an Extracorporeal Circuit

  1958cited by this paper

• Retreatment with talimogene laherparepvec for advanced melanoma.

  2020cites this paper
• Isolated Limb Infusion for Recurrent and Locally Metastatic Limb Melanoma

  2018cites this paper
• Hyperthermic Regional Perfusion for Melanoma of the Limbs

  2018cites this paper
• Isolated Limb Infusion of the Extremity

  2015cites this paper
• Chapter 5 Isolated Limb Infusion of the Extremity

  2015cites this paper
• Regional aspects of melanoma diagnosis and treatment

  2015cites this paper
• Isolierte arterielle Infusion von Extremitäten

  2013cites this paper
• A Multi-institutional Experience of Repeat Regional Chemotherapy for Recurrent Melanoma of Extremities

  2012cites this paper
• Patterns of Recurrence Following Complete Response to Regional Chemotherapy for In-Transit Melanoma

  2012influential citation
• Results of isolated lower limb perfusion for loco‐regional advanced/recurrent melanoma using borderline true hyperthermia plus additional bolus of melphalan. A critical analysis of homogeneous cases

  2011cites this paper
• Isolated limb perfusion and isolated limb infusion for malignant lesions of the extremities.

  2011cites this paper
• Effectiveness of imiquimod limited to dermal melanoma metastases, with simultaneous resistance of subcutaneous metastasis

  2010cites this paper
• Isolated limb perfusion for malignant melanoma: systematic review on effectiveness and safety.

  2010influential citation
• Efficacy of repeat isolated limb infusion with melphalan and actinomycin D for recurrent melanoma

  2009cites this paper
• Isolated limb infusion: A review

  2009cites this paper
• Melanoma localmente avanzado. Estudio y tratamiento

  2009cites this paper
• Isolated Limb Infusion

  2009cites this paper
• [Study and treatment of locally advanced melanoma].

  2009cites this paper
• Surgical management of melanoma.

  2009cites this paper
• Major Amputation for Irresectable Extremity Melanoma After Failure of Isolated Limb Infusion

  2009cites this paper
• Monitoring system for isolated limb perfusion based on a portable gamma camera

  2009cites this paper
• Current status of hyperthermic limb perfusion for in-transit melanoma

  2008cites this paper
• The European approach to in-transit melanoma lesions

  2008cites this paper
• Isolated limb perfusion for melanoma.

  2008cites this paper
• Issue 3: Treatment of Melanoma in Special Circumstances

  2007cites this paper
• Long-term Results of Hyperthermic, Isolated Limb Perfusion for Melanoma: A Reflection of Tumor Biology

  2007cites this paper
• Repeat isolated limb perfusion with TNFalpha and melphalan for recurrent limb melanoma after failure of previous perfusion.

  2006cites this paper
• Isolated limb perfusion for melanoma patients--a review of its indications and the role of tumour necrosis factor-alpha.

  2006cites this paper
• Clinical Utility of TNF-based Isolated Limb Perfusion to achieve Limb Salvage

  2006cites this paper
• Isolated limb perfusion for melanoma patients—a review of its indications and the role of tumour necrosis factor-α

  2006cites this paper
• Solid malignancies among patients in the Wegener's Granulomatosis Etanercept Trial.

  2006cites this paper
• Isolated limb perfusion in regional melanoma.

  2006cites this paper
• Major amputation for intractable extremity melanoma after failure of isolated limb perfusion.

  2005cites this paper
• Efficacy of Repeat Isolated Limb Perfusions With Tumor Necrosis Factor α and Melphalan for Multiple In-Transit Metastases in Patients with Prior Isolated Limb Perfusion Failure

  2005cites this paper
• Double isolated limb infusion with cytotoxic agents for recurrent and metastatic limb melanoma.

  2004cites this paper
• Isolated Limb Perfusion Prolongs the Limb Recurrence-Free Interval After Several Episodes of Excisional Surgery for Locoregional Recurrent Melanoma

  2004cites this paper
• Isolated limb perfusion for melanoma: results and complications

  2003cites this paper
• Long-term results of a double perfusion schedule using high dose hyperthermia and melphalan sequentially in extensive melanoma of the lower limb

  2003cites this paper
• Die isolierte Extremitätenperfusion mit Tumornekrosefaktor- und Melphalan beim lokoregionär metastasierten Melanom und bei fortgeschrittenen Weichgewebssarkomen

  2002cites this paper
• Current Concepts in the Management of Patients with Melanoma

  2002cites this paper
• Analysis of prognosis and disease progression after local recurrence of melanoma

  2000cites this paper